Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease

被引:31
|
作者
Vanhees, L
Schepers, D
Heidbüchel, H
Defoor, J
Fagard, R
机构
[1] Katholieke Univ Leuven, Fac Phys Educ & Phys Therapy, Dept Rehabil Sci, Cardiovasc & Resp Rehabil Unit, Louvain, Belgium
[2] Katholieke Univ Leuven, Fac Med, Dept Mol & Cardiovasc Res, Hypertens & Cardiovasc Rehabil Unit, Louvain, Belgium
[3] Katholieke Univ Leuven, Fac Med, Dept Mol & Cardiovasc Res, Cardiol Unit, Louvain, Belgium
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 87卷 / 06期
关键词
D O I
10.1016/S0002-9149(00)01488-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this preliminary study was to compare exercise performance and the effect of exercise training in cardiac patients with and without an implantable cardioverter-defibrillator (ICD). There are few data on exercise performance and on the effect of exercise training in patients with an ICD. Data in patients with an ICD (n = 8) were compared with those from a matched control group (n = 16). Patients performed maximal cycle-ergometer testing before and after 3 months of exercise training. All patients had to stop the exercise test for reasons of exhaustion. The predetermined heart rate threshold in ICD patients, set at the detection rate of the ICD minus 30 beats/min, was not reached. Before training, peak oxygen uptake was not different in the ICD patients compared with the control group (21.0 +/- 6.9 vs 21.9 +/- 5.0 mi oxygen standard temperature pressure dry/min/kg). Exercise training increased peak oxygen uptake to a similar extent in both groups, 20% and 24%, respectively. One ICD patient developed uneventful ventricular tachycardia at the end of the post-training exercise test, and another during training. Thus, exercise performance and the favorable response to a 3-month exercise training program are comparable in patients with ICD and matched control patients. However, tachyarrhythmias may occur during exercise testing or training and require special attention. Selected patients with ICD can be encouraged to participate in medically supervised exercise training programs. The results of this study should be confirmed with additional studies on larger numbers of subjects. (C) 2001 by Excerpta Medica, Inc.
引用
收藏
页码:712 / 715
页数:4
相关论文
共 50 条
  • [1] Implantable cardioverter-defibrillators in congenital heart disease
    Mondesert, Blandine
    Khairy, Paul
    [J]. CURRENT OPINION IN CARDIOLOGY, 2014, 29 (01) : 45 - 52
  • [2] Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease
    Waldmann, Victor
    Marquie, Christelle
    Bessiere, Francis
    Perrot, David
    Anselme, Frederic
    Badenco, Nicolas
    Barra, Sergio
    Bertaux, Geraldine
    Blangy, Hugues
    Bordachar, Pierre
    Boveda, Serge
    Chauvin, Michel
    Clementy, Nicolas
    Clerici, Gael
    Combes, Nicolas
    Defaye, Pascal
    Deharo, Jean-Claude
    Durand, Philippe
    Duthoit, Guillaume
    Eschalier, Romain
    Fauchier, Laurent
    Garcia, Rodrigue
    Geoffroy, Olivier
    Gitenay, Edouard
    Gourraud, Jean-Baptiste
    Guenancia, Charles
    Iserin, Laurence
    Jacon, Peggy
    Jesel-Morel, Laurence
    Kerkouri, Fawzi
    Klug, Didier
    Koutbi, Linda
    Labombarda, Fabien
    Ladouceur, Magalie
    Laurent, Gabriel
    Leclercq, Christophe
    Maille, Baptiste
    Maltret, Alice
    Massoulie, Gregoire
    Mondoly, Pierre
    Ninni, Sandro
    Ollitrault, Pierre
    Pasquie, Jean-Luc
    Pierre, Bertrand
    Pujadas, Penelope
    Champ-Rigot, Laure
    Sacher, Frederic
    Sadoul, Nicolas
    Schatz, Alexandre
    Winum, Pierre
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (07) : 590 - 599
  • [3] System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients
    Radbill, Andrew E.
    Triedman, John K.
    Berul, Charles I.
    Fynn-Thompson, Francis
    Atallah, Joseph
    Alexander, Mark E.
    Walsh, Edward P.
    Cecchin, Frank
    [J]. HEART RHYTHM, 2010, 7 (02) : 193 - 198
  • [4] Patterns of use of nicotine and alcohol in patients with implantable cardioverter-defibrillators versus coronary heart disease patients
    Collins, AT
    Comeno, CA
    Stamato, NJ
    [J]. HEARTWEB, 2001, 5 (08):
  • [5] Safety of sports and vigorous exercise in patients with implantable cardioverter-defibrillators
    Davids, JS
    McPherson, CA
    Earley, C
    Rosenfeld, LE
    Clancy, JF
    Lampert, R
    [J]. CIRCULATION, 2003, 108 (17) : 616 - 616
  • [6] IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    KUTALEK, SP
    DREIFUS, LS
    [J]. ADVANCES IN INTERNAL MEDICINE, VOLUME 38, 1993, 38 : 421 - 438
  • [7] Implantable cardioverter-defibrillators
    DiMarco, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19): : 1836 - 1847
  • [8] Implantable Cardioverter-Defibrillators in Patients With COPD
    Naksuk, Niyada
    Kunisaki, Ken M.
    Benditt, David G.
    Tholakanahalli, Venkatakrishna
    Adabag, Selcuk
    [J]. CHEST, 2013, 144 (03) : 778 - 783
  • [9] Implantable cardioverter-defibrillators in dialysis patients
    Mills, Mark T.
    [J]. BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (05) : 187 - 188
  • [10] Implantable cardioverter-defibrillators
    Pinski, SL
    Fahy, GJ
    [J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (04): : 446 - 458